SCHEMBL8249659

SCHEMBL8249659

CC(=O)C(C)(NC(=O)c1c(C)c(-c2ccccc2)nc2ccccc12)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.59
TSHR P16473 2/20 0.59
DHODH Q02127 2/20 0.56
TACR3 P29371 4/20 0.54
ALDH1A1 P00352 3/20 0.54
TACR2 P21452 2/20 0.54
MEN1 O00255 1/20 0.54
TP53 P04637 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
NFKB1 P19838 1/20 0.54
MAPK1 P28482 1/20 0.54
CYP2C19 P33261 1/20 0.54
BLM P54132 1/20 0.54
PMP22 Q01453 1/20 0.54
KMT2A Q03164 1/20 0.54
ATM Q13315 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
HIF1A Q16665 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7686463 0.89 TSHR (0.56) PDE10ATSHRDHODHTACR3ALDH1A1
SCHEMBL7686462 0.89 TSHR (0.56) PDE10ATSHRDHODHTACR3ALDH1A1
SCHEMBL2007335 0.77 CYP2D6 (0.62) PDE10ATSHRDHODHTACR3ALDH1A1
SCHEMBL2053743 0.76 TACR3 (0.58) PDE10ATSHRDHODHTACR3CYP3A4
SCHEMBL2013005 0.76 TACR3 (0.59) PDE10ATSHRTACR3TACR2TP53
SCHEMBL1581468 0.75 PDE10A (1.00) PDE10ATSHRDHODHCYP2C19KMT2A
SCHEMBL4984967 0.75 LMNA (0.47) PDE10ATSHRTACR3TACR2TP53
SCHEMBL4993354 0.75 LMNA (0.47) PDE10ATSHRTACR3TACR2TP53
SCHEMBL4475835 0.75 TACR3 (0.58) PDE10ATSHRDHODHTACR3TACR2
SCHEMBL4558032 0.75 DHODH (0.60) PDE10ATSHRDHODHTACR3TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1019377-A1 QUINOLINE-4-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS NEUROKININ 3 (NK-3)- AND NEUROKININ 2 (NK-2) RECEPTOR ANTAGONISTS. Smithkline Beecham S.p.A. (IT) 2000-07-19 EP disclosed
WO-1997019926-A1 QUINOLINE-4-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS NEUROKININ 3 (NK-3)- AND NEUROKININ 2 (NK-2) RECEPTOR ANTAGONISTS. SMITHKLINE BEECHAM S.P.A. (IT) 1997-06-05 WO disclosed